Olimel 7.6% 4.53 g

OlimeL 7.6% 4.53 G is an intravenous emulsion containing L-Proline, designed to support amino acid therapy. This product is manufactured by Baxter Corporation in Canada and is commonly used for nutritional supplementation.

OlimeL 7.6% 4.53 G is primarily used for intravenous administration of L-Proline, an essential amino acid. It is often utilized in clinical settings to support nutritional needs, particularly in patients who require amino acid therapy. L-Proline is known for its role in the synthesis of collagen and the maintenance of skin, joints, and tendons. This product is not intended for self-administration without medical supervision.

When administered intravenously, OlimeL 7.6% 4.53 G provides essential amino acids to the body. Patients may experience improved nutritional status and support for tissue repair and maintenance. As with any intravenous therapy, individual responses can vary, and it is important to monitor for any adverse reactions.

OlimeL 7.6% 4.53 G should only be administered by healthcare professionals in a controlled medical setting. Patients with known allergies to any of the components should avoid its use. Proper handling and storage are crucial to maintain the integrity of the emulsion. Always follow the guidelines provided by the healthcare provider.

OlimeL 7.6% 4.53 G may interact with other medications or supplements, particularly those that affect amino acid metabolism. It is important to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain dietary supplements may also influence the effectiveness of this therapy.